I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| natural killer cell | 14 studies | 21% ± 5% | |
| CD16-positive, CD56-dim natural killer cell, human | 8 studies | 21% ± 5% | |
| epithelial cell | 6 studies | 27% ± 7% | |
| CD16-negative, CD56-bright natural killer cell, human | 5 studies | 18% ± 2% | |
| plasmablast | 4 studies | 40% ± 22% | |
| mature NK T cell | 4 studies | 17% ± 1% | |
| endothelial cell | 4 studies | 21% ± 4% | |
| glutamatergic neuron | 4 studies | 47% ± 18% | |
| oligodendrocyte | 4 studies | 21% ± 3% | |
| neuron | 3 studies | 21% ± 6% | |
| retinal cone cell | 3 studies | 32% ± 4% | |
| ciliated cell | 3 studies | 19% ± 3% | |
| effector CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| GABAergic neuron | 3 studies | 43% ± 5% | |
| dendritic cell | 3 studies | 22% ± 2% | |
| macrophage | 3 studies | 18% ± 2% | |
| basal cell | 3 studies | 25% ± 3% | |
| interneuron | 3 studies | 37% ± 17% | |
| plasmacytoid dendritic cell | 3 studies | 24% ± 3% | |
| astrocyte | 3 studies | 24% ± 8% | |
| CD8-positive, alpha-beta T cell | 3 studies | 24% ± 7% |
